Late stage attrition is high in novel compounds, with only a fraction making it
through approval.
Our facility in Verona has in-depth knowledge and understanding of robust lead identification
and optimization, which makes candidate selection quicker, more accurate and cost-effective,
resulting in a higher quality molecule.
Adopting this totally integrated strategy and continuous dialogue across the various
phases has a number of benefits - it refines the processes involved, improves the
integrity of the identified molecule and greatly enhances the chances of success,
helps refine the processes involved, improving the quality of the identified molecule
and its likely success.